Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Craig I Coleman

Showing results (1-10 of 351) with videos related to

Pageof 36
Sort By:
American Journal of Pharmaceutical Education|April 24, 2013
College and school of pharmacy characteristics associated with US News and World Report rankingsLauren Schlesselman, Craig I Coleman
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|May 5, 2026
Impact of New York Heart Association classification on transthyretin stabilizer efficacy in transthyretin amyloid cardiomyopathy: A meta-analysisHuiqiao Fan, Craig I Coleman
The Lancet. Haematology|March 31, 2019
Can apixaban prevent venous thromboembolism better than rivaroxaban?Craig I Coleman, William L Baker
The American Journal of Cardiology|May 2, 2013
Cost-effectiveness of universal and platelet reactivity assay-driven antiplatelet therapy in acute coronary syndromeCraig I Coleman, Brendan L Limone
Future Cardiology|April 22, 2021
Welcome to the cardiovascular outcomes trials issueCraig I Coleman, Olivia S Costa
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|June 6, 2015
Medication adherence and non-vitamin K antagonist oral anticoagulants: what do we really know?William L Baker, Craig I Coleman
Thrombosis and Haemostasis|October 19, 2013
Universal versus platelet reactivity assay-driven use of P2Y12 inhibitors in acute coronary syndrome patients: cost-effectiveness analyses for six European perspectivesCraig I Coleman, Brendan L Limone
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|November 4, 2016
Meta-analysis of ascorbic acid for prevention of postoperative atrial fibrillation after cardiac surgeryWilliam L Baker, Craig I Coleman
Connecticut Medicine|June 14, 2006
The effect of Echinacea on upper respiratory infection symptom severity and quality of lifeEffie L Gillespie, Craig I Coleman
Connecticut Medicine|September 21, 2007
The impact of statin use on the mortality of patients with bacteremiaDiana M Lucek, Craig I Coleman
Pageof 36

Showing results (1-10 of 351) with videos related to

Sort By:
Pageof 36
American Journal of Pharmaceutical Education|April 24, 2013
College and school of pharmacy characteristics associated with US News and World Report rankingsLauren Schlesselman, Craig I Coleman
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|May 5, 2026
Impact of New York Heart Association classification on transthyretin stabilizer efficacy in transthyretin amyloid cardiomyopathy: A meta-analysisHuiqiao Fan, Craig I Coleman
The Lancet. Haematology|March 31, 2019
Can apixaban prevent venous thromboembolism better than rivaroxaban?Craig I Coleman, William L Baker
The American Journal of Cardiology|May 2, 2013
Cost-effectiveness of universal and platelet reactivity assay-driven antiplatelet therapy in acute coronary syndromeCraig I Coleman, Brendan L Limone
Future Cardiology|April 22, 2021
Welcome to the cardiovascular outcomes trials issueCraig I Coleman, Olivia S Costa
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|June 6, 2015
Medication adherence and non-vitamin K antagonist oral anticoagulants: what do we really know?William L Baker, Craig I Coleman
Thrombosis and Haemostasis|October 19, 2013
Universal versus platelet reactivity assay-driven use of P2Y12 inhibitors in acute coronary syndrome patients: cost-effectiveness analyses for six European perspectivesCraig I Coleman, Brendan L Limone
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|November 4, 2016
Meta-analysis of ascorbic acid for prevention of postoperative atrial fibrillation after cardiac surgeryWilliam L Baker, Craig I Coleman
Connecticut Medicine|June 14, 2006
The effect of Echinacea on upper respiratory infection symptom severity and quality of lifeEffie L Gillespie, Craig I Coleman
Connecticut Medicine|September 21, 2007
The impact of statin use on the mortality of patients with bacteremiaDiana M Lucek, Craig I Coleman
Pageof 36